Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories are trading higher by 2 percent.

Sun Pharma stock surged 2 percent to Rs 707, while Ranbaxy Laboratories gained 2 percent to Rs 534.

USFDA has granted approval to Ranbaxy’s subsidiary Ohm Laboratories to manufacture and sell generic Diovan in the US.

Source: IIFL

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related Corporate Updates